Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Sjælland Forside
Hjælp og OSS
Link åbnes på en ny fane
Dansk
English
Søg efter indhold i Region Sjælland
Forside
Profiler
Forskningsenheder
Projekter
Publikationer
Priser
Aktiviteter
Undervisning og vejledning
Presse/medier
Impacts
Rising burden of PRL-PitNETs: patterns across tumour sizes and incidentalomas
Frederik Østergaard Klit
*
, Sara Faartoft Nørgård
, Anna-Sofie Dam Berrett
, Christian Rosendal
, Amar Nikontovic
, Peter Vestergaard
,
Jesper Krogh
, Kirstine Stochholm
, Jakob Dal
*
Corresponding author af dette arbejde
Medicinsk Afdeling Køge
Publikation
:
Bidrag til tidsskrift
›
Artikel
›
Forskning
›
peer review
Oversigt
Fingeraftryk
Fingeraftryk
Udforsk hvilke forskningsemner 'Rising burden of PRL-PitNETs: patterns across tumour sizes and incidentalomas' indeholder.
Sorter
Vægt
Alfabetisk
Keyphrases
Tumor Size
100%
Prolactin
100%
Pituitary Neuroendocrine Tumor (PitNET)
100%
Tumor Pattern
100%
Incidentaloma
100%
Meta-analysis
37%
Macroprolactinoma
37%
Microprolactinoma
25%
Denmark
12%
Age of Onset
12%
PubMed
12%
Embase
12%
Tumor Characteristics
12%
Age Distribution
12%
Epidemiology
12%
ICD-10 Codes
12%
Treatment Burden
12%
Age at Diagnosis
12%
Heterogeneous Disease
12%
Random Effects
12%
Tumor Patients
12%
Sex Distribution
12%
Epidemiological Trends
12%
Prolactin Levels
12%
Rising Incidence
12%
Onset Characteristics
12%
Phenotypical
12%
Prevalence Distribution
12%
Extracted Data
12%
Overall Incidence
12%
Prevalence/incidence
12%
Care Burden
12%
Medicine and Dentistry
Neuroendocrine Tumor
100%
Prolactin
100%
Tumor
100%
Incidentaloma
100%
Prolactinoma
55%
Prevalence
33%
Meta-Analysis
33%
Systematic Review
33%
Cohort Analysis
22%
Onset Age
11%
Cohort Effect
11%
Age Distribution
11%
Adenoma
11%
ICD-10
11%
Dopamine Agonist
11%
Sex Ratio
11%
Diseases
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prolactin
100%
Neuroendocrine Tumor
100%
Incidentaloma
100%
Prolactinoma
55%
Prevalence
33%
Cohort Study
22%
Adenoma
11%
ICD-10
11%
Dopamine Receptor Stimulating Agent
11%
Onset Age
11%
Diseases
11%
Epidemiology
11%